Vext Science Share Buybacks
Share Buybacks of Vext Science (VEXT.CN) as of Aug 26, 2026.
Get this data via API
Financial Data API
Share Buybacks
0.00USD
Last updated:
Share Buybacks of Vext Science is 2026 0.00 USD. Share Buybacks of Vext Science was 2025 11.50 M USD. It decreases by % lower compared to the previous year.
The Vext Science Share Buybacks history
3 Years
10 Years
25 Years
Max
Share Buybacks
Date
Share Buybacks
Jan 1, 2018
3.50 M USD
Jan 1, 2019
5.15 M USD
Jan 1, 2020
5.51 M USD
Jan 1, 2021
18.58 M USD
Jan 1, 2022
129,900.00 USD
Jan 1, 2023
11.50 M USD
Jan 1, 2024
0.00 USD
| YEAR | Share Buybacks | YoY |
|---|---|---|
| 0.00USD | -100.00% | |
| 11.50 MUSD | +8,750.42% | |
| 129,900.00USD | -99.30% | |
| 18.58 MUSD | +237.22% | |
| 5.51 MUSD | +6.90% | |
| 5.15 MUSD | +47.18% | |
| 3.50 MUSD | — |
Access this data via the Eulerpool API
Vext Science Stock analysis
What does Vext Science do? Vext Science Inc. is a Canadian company specializing in the production and sale of cannabis products. The company was established in 2015 and has gained a high reputation due to its innovative business models and quality, effective products.
Vext Science Inc. aims to make cannabis products accessible for various applications while meeting the highest standards. The company works closely with cannabis breeders to obtain the best quality cannabis products, with a focus on organic and natural cultivation.
Vext Science Inc. operates in three divisions: Vapen, Vapen CBD, and Pure Touch Botanicals. The Vapen division produces and distributes traditional cannabis products such as flowers, capsules, and oils. Vapen CBD offers a wide range of CBD products, including oils, creams, lotions, and capsules. The emphasis in this division is on utilizing the benefits of cannabinoids for pain relief and stress management. Pure Touch Botanicals offers a wide range of natural herbal products for wellness enhancement, including tea, herbal capsules, and supplements.
Vext Science Inc.'s business model is based on creating partnerships with other companies and individuals. The company collaborates with immigrants and community members to create jobs and stimulate local economic growth. Vext Science Inc. focuses on an efficient value chain to provide customer-oriented service.
Vext Science Inc.'s products are popular among consumers and valued for their quality and natural ingredients. The company places great importance on research and development to ensure its products meet the highest quality standards.
The future of Vext Science Inc. looks promising as the company plans further expansion in the coming years. The company aims to bring its products to the global market and expand its product range with specialized supplements. Vext Science Inc. aims to continue offering innovative and high-quality products to promote the well-being and health of its customers.
In summary, Vext Science Inc. is a leading company in the cannabis industry specializing in the production and sale of high-quality, natural products. The company prides itself on maintaining an ethical, transparent, and stable business practice built on partnerships. Although Vext Science Inc. is still relatively young, the company demonstrates a clear vision and ambitious plan, indicating a promising future. Vext Science is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Vext Science stock
On Eulerpool you can find the complete historical development of Share Buybacks Vext Science since 2006 – with annual values, charts, and detailed analysis.
Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.
Share Buybacks's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's Vext Science historically and in real time.
Access this data via the Eulerpool API
Cash Flow — Vext Science
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — Vext Science
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth